Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP413314.RA_dVEqB5mqEzKAzGjEoW_EgoRr3NHXhVlpE8MJPFLZ2U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP413314.RA_dVEqB5mqEzKAzGjEoW_EgoRr3NHXhVlpE8MJPFLZ2U130_assertion type Assertion NP413314.RA_dVEqB5mqEzKAzGjEoW_EgoRr3NHXhVlpE8MJPFLZ2U130_head.
- NP413314.RA_dVEqB5mqEzKAzGjEoW_EgoRr3NHXhVlpE8MJPFLZ2U130_assertion description "[Shh and its target transcription factor, Gli1 mRNA, were assessed by RT-PCR and/or quantitative RT-PCR in co-cultured cell recombinants comprised of AI C4-2 either with NPF (prostate fibroblasts from normal/benign prostate gland) or CPF (cancer-associated stromal fibroblasts) under Shh/cyclopamine (a hedgehog signaling inhibitor) treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413314.RA_dVEqB5mqEzKAzGjEoW_EgoRr3NHXhVlpE8MJPFLZ2U130_provenance.
- NP413314.RA_dVEqB5mqEzKAzGjEoW_EgoRr3NHXhVlpE8MJPFLZ2U130_assertion evidence source_evidence_literature NP413314.RA_dVEqB5mqEzKAzGjEoW_EgoRr3NHXhVlpE8MJPFLZ2U130_provenance.
- NP413314.RA_dVEqB5mqEzKAzGjEoW_EgoRr3NHXhVlpE8MJPFLZ2U130_assertion SIO_000772 21520153 NP413314.RA_dVEqB5mqEzKAzGjEoW_EgoRr3NHXhVlpE8MJPFLZ2U130_provenance.
- NP413314.RA_dVEqB5mqEzKAzGjEoW_EgoRr3NHXhVlpE8MJPFLZ2U130_assertion wasDerivedFrom befree-20150227 NP413314.RA_dVEqB5mqEzKAzGjEoW_EgoRr3NHXhVlpE8MJPFLZ2U130_provenance.
- NP413314.RA_dVEqB5mqEzKAzGjEoW_EgoRr3NHXhVlpE8MJPFLZ2U130_assertion wasGeneratedBy ECO_0000203 NP413314.RA_dVEqB5mqEzKAzGjEoW_EgoRr3NHXhVlpE8MJPFLZ2U130_provenance.